Sat, March 12, 2011
Fri, March 11, 2011
Thu, March 10, 2011
Wed, March 9, 2011
Tue, March 8, 2011
[ Tue, Mar 08th 2011 ] - Market Wire
Yangarra Grants Stock Options
Mon, March 7, 2011

Fibrocell Science, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference


//stocks-investing.news-articles.net/content/201 .. roth-23rd-annual-oc-growth-stock-conference.html
Published in Stocks and Investing on Thursday, March 10th 2011 at 5:15 GMT by Market Wire   Print publication without navigation


EXTON, Pa.--([ BUSINESS WIRE ])--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Companya™s Chairman and CEO, will be presenting at the ROTH 23rd Annual OC Growth Stock Conference to be held on March 13-16 at the Ritz-Carlton in Laguna Niguel, California.

Fibrocella™s presentation is scheduled for Wednesday, March 16, at 1:00 p.m. Pacific Time.

About Fibrocell Science, Inc.

Fibrocell Science, Inc. (OTCBB: FCSC) is a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well its innovative cellular processing technology and manufacturing excellence. For additional information, please visit [ www.fibrocellscience.com ].


Publication Contributing Sources